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o test the hypothesis that fast anterograde molecular
motor proteins power the slow axonal transport of
neuroﬁlaments (NFs), we used homologous recombi-
nation to generate mice lacking the neuronal-speciﬁc con-
ventional kinesin heavy chain, KIF5A. Because null KIF5A
mutants die immediately after birth, a synapsin-promoted
Cre-recombinase transgene was used to direct inactivation
of KIF5A in neurons postnatally. Three fourths of such mutant
mice exhibited seizures and death at around 3 wk of age;
the remaining animals survived to 3 mo or longer. In young
T
 
mutant animals, fast axonal transport appeared to be intact,
but NF-H, as well as NF-M and NF-L, accumulated in the
cell bodies of peripheral sensory neurons accompanied by
a reduction in sensory axon caliber. Older animals also
developed age-dependent sensory neuron degeneration, an
accumulation of NF subunits in cell bodies and a reduction
in axons, loss of large caliber axons, and hind limb paralysis.
These data support the hypothesis that a conventional kinesin
plays a role in the microtubule-dependent slow axonal
transport of at least one cargo, the NF proteins.
 
Introduction
 
Axonal transport in neurons is essential because of the extreme
polarity and size of these cells. In humans, some neurons,
such as spinal motor and sensory neurons, extend axons of 1 m
or more in length to reach postsynaptic targets in the periphery.
Because the axon has little or no protein synthesis machinery,
axonal proteins must be synthesized in the cell bodies and
transported to the nerve terminals via axonal transport.
Membranous organelles, such as synaptic vesicle precursors,
mitochondria, and other vesicles, are transported by the fast
axonal transport system. Cytoskeletal proteins, such as neu-
rofilament (NF)* proteins, are moved by the slow axonal
transport system.
Although numerous studies demonstrate that kinesin and
its relatives are the motor proteins driving fast anterograde
axonal transport, the existence and identity of motor proteins
powering slow axonal transport have been controversial and
mysterious. Some experiments suggest that NF subunits
move anterogradely in axons through a microtubule- and
energy-dependent mechanism (Koehnle and Brown, 1999;
Yabe et al., 1999). Other in vitro experiments suggested the
possible involvement of conventional kinesin (called kinesin-I)
in the slow axonal transport of NF-L (61 kD), NF-M (90
kD), and NF-H (115 kD) (Yabe et al., 1999). Kinesin-I was
also reported to associate with vimentin-containing structures
in nonneural cells (Prahlad et al., 1998). Recently, GFP-
tagged NF-M has been shown to move in a rapid, intermittent,
and highly asynchronous manner in cultured nerve cells
(Wang et al., 2000). Together these observations have raised
the possibility, still not rigorously tested, that the slow rate of
slow axonal transport may be the result of rapid movements
driven by a fast motor protein interrupted by prolonged
pauses. Thus, it is possible that a fast axonal transport motor
such as kinesin-I could be involved in the transport of these
intermediate filament proteins at a slow net rate.
Kinesin-I was first found in squid axoplasm and was the
first identified member of the kinesin superfamily (Brady,
1985; Vale et al., 1985). Native kinesin-I is a heterotetramer
composed of two kinesin heavy chain (KHC) subunits
(110–130 kD) and two kinesin light chain (KLC) subunits
 
(60–70 kD) (Bloom et al., 1988). KHC has a motor domain
that interacts with the microtubule track and hydrolyzes ATP.
KLC subunits are probably involved in cargo binding or mod-
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ulation of KHC activity (Bloom and Endow, 1995; Goldstein
and Philp, 1999; Rahman et al., 1999; Kamal et al., 2000).
Although only one conventional KHC gene is found in many
species, including 
 
Drosophila melanogaster
 
 and 
 
Caenorhabditis
elegans
 
, mammals have three KHC genes (KIF5A, KIF5B, and
KIF5C). KIF5B appears to be ubiquitously expressed, whereas
both KIF5A and KIF5C appear to be expressed only in neu-
ronal tissues (Navone et al., 1992; Niclas et al., 1994; Meng et
al., 1997; Xia et al., 1998). The functions of KIF5A and
KIF5C are unknown, although KIF5C has been suggested to
be important for the viability of motor neurons (Kanai et al.,
2000), and KIF5A mutations have been found to cause a form
of hereditary spastic paraplegia in humans (SPG10; Reid et
al., 2002). Although conventional kinesin has been suggested
to play a role in the slow axonal transport of NFs (Koehnle
and Brown, 1999; Yabe et al., 1999), the identity of the KHC
isoform that might be involved is unclear. To investigate the
function of KIF5A, and to test the role of KIF5A in the slow
axonal transport of NFs, we have now generated and analyzed
null and conditional KIF5A mutants in mice.
 
Results
 
KIF5A null mutants were lethal
 
We made a KIF5A deletion mutant by homologous recom-
bination. The strategy (Fig. 1 A) was to create a null mutant
by deleting two critical exons, causing a frame shift of the
encoded protein. Mice heterozygous for the KIF5A null mu-
tation were mated, and 33 newborn offspring from four lit-
ters were analyzed. Initial genotyping revealed that no
KIF5A homozygous mutants survived, only three dead ho-
mozygous pups were found. Thus, KIF5A null mutants are
probably neonatal lethal. To directly observe the behavior of
KIF5A null mutants, KIF5A heterozygous mice were mated,
the pregnant female mice were killed by caesarian section
(c-section), and the embryonic day 18.5 (E18.5) pups were
genotyped. Although live null mutant pups were never ob-
served by natural birth, all null pups recovered by c-section
were alive at E18.5. Whereas control littermates quickly de-
veloped a normal breathing pattern, the mutant pups did
not (although like control littermates, they gasped just after
removal from the uterus). Mutant pups gradually turned
blue and usually died within 10 min. In a mixed 129/
C57BL background, a total of 45 litters of E18.5 pups ob-
tained by c-section were PCR genotyped. The predicted
Mendelian ratio of 1:2:1 was observed: wild type (83/309),
heterozygous (153/309), and homozygous mutant (73/309).
The KIF5A homozygous mutant pups were indistinguish-
able from their control littermates by size and appearance.
No visible structural defects were observed in any organs.
Immunoblots with a KIF5A polyclonal antibody of brain
extracts of wild-type, heterozygous, and homozygous KIF5A
Figure 1. Targeted disruption of the mouse KIF5A gene. 
(A) KIF5A gene targeting strategy. In the targeting vector, the 
pGK-neo and HSV-tk selection cassette was flanked by two 
loxP sites (loxP1 and loxP2), and the two exons to be deleted 
were flanked by loxP2 and loxP3. Two steps of transfection 
were performed to generate type I deletion (null mutant) and 
type II deletion ES cells. The first step was done by transfecting linearized targeting vector into ES cells followed by G418 selection; the 
second step was performed by transfecting a Cre plasmid into recombinant ES cells isolated from the first step, followed by Gancyclovir 
selection. (B and C) Southern blot analyses of HindIII-digested G418-resistant ES clones after transfecting targeting vector. (B) A 5  external 
probe was used to identify the recombinant clones. A 4.7-kb wild-type band was detected, and an additional 8.2 kb (with the addition of a 
3.5-kb selection cassette) was also detected in the recombinant clones. (C) The presence of three loxP sites was confirmed by a loxP probe. 
The correct recombinant clones should have all three loxP sites, both 8.2-kb and 2.5-kb bands should be detected by the probe (clones 2 and 
3), whereas clones 1 and 4 only had the first two loxP sites. (D) Southern blot analysis of HindIII-digested Gancyclovir-resistant clones after 
Cre transfection. With the loxP probe, only a 6-kb band was detected in type I deletion (KIF5A
null) ES cells, whereas 4.7-kb and 2.5-kb bands 
were detected in type II (KIF5A
flox) ES cells. (E) No KIF5A protein was detected in KIF5A null mutant mice by Western blot analysis. Mouse 
brain homogenates were made from two litters of mice, and 100  g of protein was loaded in each lane. Isoform-specific antibodies were 
used to probe KIF5A, KIF5B, and KIF5C;  -tubulin was used as a loading control.T
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mutant littermates revealed that KIF5A was totally absent in
the homozygous mice (Fig. 1 E). Heterozygous mice had re-
duced KIF5A as expected. Reprobing the blot with KIF5B
and KIF5C antibodies showed no significant change in the
amount of either in the KIF5A mutant.
Because KIF5A null mutant pups delivered by c-section
died soon after birth and did not develop a normal breathing
pattern as control littermates did, lungs from mutant and
control littermates were sectioned and stained with hema-
toxylin-eosin. KIF5A mutant lungs did not expand as well as
those of control littermates (Fig. 2 A). Thus, unexpanded
lungs may be the cause of death, although the nature of the
underlying mechanism is unclear. The diaphragm muscle
was studied by immunostaining and electron microscopy to
examine whether the neuromuscular junction region and
muscle structure developed normally. No consistent abnor-
mality was found in the mutant (unpublished data).
Because KIF5A is only found in neurons, histological
analysis of the brain and spinal cord was performed. No ob-
vious pathological changes were observed in the KIF5A mu-
tant brain (Fig. 2, D–F). Interestingly, nuclei and cell bod-
ies of spinal cord motor neurons of the KIF5A mutant
appeared to be bigger than motor neurons of control litter-
mates (Fig. 2, B and C). Hippocampal neurons cultured
from KIF5A null mutants did not show any morphological
difference when compared with cells from control litter-
mates. Electrophysiology of these cells did not reveal any
 
defect in synaptic transmission caused by the absence of
KIF5A (unpublished data).
 
Cre-mediated postnatal loss of KIF5A causes seizures 
and sensory neuron degeneration
 
To understand better the lethality caused by loss of KIF5A,
and to test whether KIF5A might have a role in slow axonal
transport of NFs, we constructed a conditional KIF5A mu-
tant, which was combined with a transgene encoding the
Cre recombinase under the control of the synapsin I pro-
moter (Cre
 
synapsin
 
) (Zhu et al., 2001). This transgene is
known to be a neuron-specific, developmentally regulated
gene whose expression follows a biphasic postnatal time
course with a maximum around day 20 (Hoesche et al.,
1993). By mating KIF5A
 
flox
 
/KIF5A
 
flox
 
 mice to KIF5A
 
null
 
/
KIF5A
 
WT
 
; Cre
 
synapsin
 
 mice, KIF5A
 
null
 
/KIF5A
 
flox
 
; Cre
 
synapsin
 
 off-
spring were identified.
Quantitative immunoblot analysis of a small set of initial
animals showed that KIF5A protein levels in mutant brains
ranged from 6 to 56% of that of control brains (Fig. 3 A).
The heterogeneity in the level of reduction of KIF5A may
reflect variable efficiency of Cre-mediated gene excision.
To observe directly KIF5A excision at the cellular level,
dorsal root ganglion (DRG) and spinal cord from 
 
 
 
3-wk-
old mutants were examined by immunostaining with a
KIF5A-specific antibody (Fig. 3, B and C). This staining
Figure 2. Histology of KIF5A null mutant mice. (A) Lung histology of KIF5A null mutant. 7- m lung paraffin sections from KIF5A null 
(KIF5A
null/KIF5A
null) and control (KIF5A
WT/KIF5A
WT) littermates were stained with hematoxylin and eosin. Note that the mutant lung was not 
well expanded. Bar, 50  m. (B–F) Histology of KIF5A null mutant nervous tissues. Paraffin sections from spinal cord (B and C), cortex (D), 
hippocampus (E), and cerebellum (F) were stained with cresyl violet. Note that no obvious differences were observed between KIF5A null 
mutant and control littermates except that the cell bodies of the motor neurons were larger in the mutant spinal cord. Bars: (B, D, and F) 50  m; 
(C) 20  m; (E) 100  m.T
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revealed an absence of KIF5A in some sensory neurons in
the mutant. In spinal cord, costaining with a monoclonal
BIP antibody (an endoplasmic reticulum marker) indicated
that KIF5A staining in the mutant motor neuron cell bod-
ies was much weaker compared with the control; some cells
had almost no KIF5A staining. We conclude that KIF5A
excision occurred in many DRG sensory neurons and spi-
nal cord motor neurons.
As predicted, KIF5A
 
null
 
/KIF5A
 
flox
 
; Cre
 
synapsin
 
 mice sur-
vived the critical neonatal stage as did control littermates
(KIF5A
 
null
 
/KIF5A
 
flox
 
, KIF5A
 
flox
 
/KIF5A
 
WT
 
, and KIF5A
 
flox
 
/
KIF5A
 
WT
 
; Cre
 
synapsin
 
). By 2–3 wk of age, however, mutant
mice were obviously smaller than their littermates. At 3 wk,
the weight of mutant mice was only 
 
 
 
50% of the control
weight (Fig. 3 D). These mice responded to pinch (a crude
sensory test), but they fell much more frequently than wild-
type mice on a rotorod device (unpublished data). It is diffi-
cult to assess whether these problems result from motor de-
fects or sensory defects. At 3 wk of age, KIF5A
 
null
 
/KIF5A
 
flox
 
;
Cre
 
synapsin
 
 mutant mice exhibited a relatively normal posture,
although they frequently exhibited a tremor.
In an initial cohort, 142 mice from 16 litters were fol-
lowed (29 KIF5A
 
null
 
/KIF5A
 
flox
 
; Cre
 
synapsin
 
 mutant mice and
113 littermate control mice in a mixed 129/C57BL back-
ground), and survival curves were plotted (Fig. 3 E). 21/29
(72%) of the mutant mice died between day 15 and day 25;
these mice appeared to die of seizures. Spontaneous seizures
were observed as well as seizures apparently induced when
Figure 3. Gross analysis of KIF5A conditional mutant mice (KIF5A
null/KIF5A
flox; Cre
synapsin). (A) Western blot analysis to measure KIF5A 
protein levels in the brains of KIF5A
null/KIF5A
flox; Cre
synapsin mice. Equal amounts of brain homogenate from 3-wk-old mutant and control 
(KIF5A
flox/KIF5A
WT) littermates were loaded; actin was used as a loading control. Each marked number represents the ratio between the 
mutant band and control band after normalizing with the actin band. (B and C) KIF5A excision by Cre
synapsin transgene in DRG (B) and spinal 
cord motor neurons (C) of KIF5A
null/KIF5A
flox; Cre
synapsin mutant. Tissue sections from  3-wk-old mutant and control littermates were stained 
with KIF5A-specific antibody. Spinal cord sections were also double stained with an anti-BIP antibody to visualize the motor neuron cell bodies. 
Note the decreased or lack of KIF5A staining in some neurons (arrowheads). Bar, 100  m. (D) A comparison of body weight (mean   SD) 
among 3-wk-old littermates with different genotypes. Note the obvious low body weight in the KIF5A
null/KIF5A
flox; Cre
synapsin mutant group, 
n   4 for each group. *, P   0.01. (E) Most KIF5A
null/KIF5A
flox; Cre
synapsin mutant mice died around 3 wk of age. Postnatal survival curve of 
a group of mice (142 total, 113 control and 29 mutant) is shown here. The rate of survival of the different genotypes was plotted against age. 
(F) Abnormal hind limb posture in an older KIF5A
null/KIF5A
flox; Cre
synapsin mutant mouse. Two 7.5-mo-old littermates (control and KIF5A
null/
KIF5A
flox) are shown.T
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animals were stressed. Each seizure episode lasted 
 
 
 
20–30 s;
repetitive seizure was observed, and the mice usually did not
recover from severe seizures. Distinct from the 72% of mice
that died at 3 wk of age, the remaining 
 
 
 
28% of mice lived
 
 
 
3 mo. This pool contains eight animals; among these eight
mice, one died at 3 mo, one at 4 mo, and another at 5.5 mo
(the remaining mice were killed for experiments at 5.5, 7,
and 8 mo). All mutant mice that survived to 5 mo of age
showed almost normal posture until 
 
 
 
5 mo (Fig. 3 F), but
after that they developed a tremor when walking. The hind
limbs behaved abnormally during walking, although they
were not completely paralyzed, and the animals adopted ab-
normal hind limb posture during resting.
In spite of the obvious neuromuscular phenotype, no ob-
vious morphological abnormality in spinal cord or DRG was
observed in KIF5A
 
null
 
/KIF5A
 
flox
 
; Cre
 
synapsin
 
 mutants at either
3 wk or 7.5 mo of age (unpublished data). Examination of
thin sections of ventral roots (Fig. 4 A) did not detect any
obvious abnormality in 3-wk-, 5.5-mo-, or 7.5-mo-old mu-
tant mice. Whereas no degeneration was detected in sensory
axons of the dorsal roots from 3-wk-old animals (Fig. 4 B),
four older mutant mice (two 5.5- and two 7.5-mo-old mice)
showed striking degeneration of axons (Fig. 4 B), with nu-
merous profiles of myelin debris (typical of Wallerian degen-
eration). This phenotype was not observed in the control lit-
termates (KIF5A
 
flox
 
/KIF5A
 
WT
 
 or KIF5A
 
null
 
/KIF5A
 
flox
 
). These
data are consistent with an age-dependent onset of abnormal
hind limb posture after loss of KIF5A.
 
Loss of large caliber axons and NF transport defects 
caused by postnatal loss of KIF5A
 
To determine quantitatively whether the loss of KIF5A af-
fected the survival of motor and/or sensory axons, axons of
the lumbar sciatic nerve roots were counted. Comparison of
the number of L5 lumbar motor axons within ventral roots
of 3-wk-old KIF5A-depleted mutants and control litter-
mates (Fig. 5 A) revealed no significant axon loss (P 
 
 
 
0.112), indicating that loss of KIF5A had no significant ef-
fect on the survival of motor neurons at 3 wk of age. How-
ever, sensory axon numbers within dorsal roots (Fig. 5 A)
were significantly reduced in the 3-wk-old KIF5A–synapsin
Cre mutant animals (
 
 
 
86% of control; P 
 
 
 
 0.045). Mea-
surement of axonal diameter also revealed sensory loss re-
flected by a preferential loss of large caliber sensory axons.
60% (P 
 
 
 
 0.002) of large caliber (
 
 
 
3 
 
 
 
m in diameter) sen-
sory axons were lost, whereas no significant loss (P 
 
 
 
 0.26)
was observed for small caliber axons.
By 5.5 mo of age, we observed a small loss (
 
 
 
12%) of
motor axons and a profound loss (
 
 
 
36%) of sensory axons
(
 
n
 
 
 
 
 
 two control and two mutant animals) (Fig. 5 B).
Again, sensory and motor (Fig. 5, C and D) axon loss was
most substantial for axons 
 
 
 
4 
 
 
 
m. Motor axons still
showed a typical bimodal distribution of axonal sizes in both
wild-type and KIF5A-depleted neurons, but the calibers of
the large axons were clearly shifted to smaller sizes in the
mutant group, and there was an obvious loss of 
 
 
 
7.5-
 
 
 
m
large caliber axons. In the dorsal roots (Fig. 5 D), profound
Figure 4. Sensory axon degeneration in 
KIF5A
null/KIF5A
flox; Cre
synapsin mutant mice. 
(A) Ventral roots of 3-wk-old and 5.5-mo-old 
mutant mice. Note the lack of degeneration. 
Bar, 50  m. (B) Dorsal roots of 3-wk-old and 
5.5-mo-old mutant mice. Note the lack of 
degeneration in 3-wk sensory axons, but in the 
5.5-mo-old mutant, there are large numbers of 
degenerating axons (arrowheads) and a striking 
decrease of large caliber axons. Bar, 20  m.T
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axon loss was observed in sensory axons with calibers  2
 m, with complete loss of the largest sensory axons ( 7
 m), but no loss of small caliber sensory axons ( 1.5  m).
Many earlier efforts demonstrated that NF content in ax-
ons is a major determinant of axonal caliber (for reviews see
Zhu et al., 1997, 1998). Concomitant with myelination be-
ginning at weeks 2–3 and continuing through young adult-
hood ( 5 mo), there is a rapid growth in axonal calibers
(e.g., see Fig. 4, A and B). Loss of acquisition of the correct
caliber by KIF5A-deficient axons, especially of the largest,
most NF-rich axons, suggested that KIF5A might be one
motor for NF transport into axons.
To test whether diminished axonal caliber was caused by
reduced NF transport into, and accumulation within, sen-
sory axons, we used immunoblotting of extracts of DRGs
(comprised primarily of the cell bodies of sensory neurons).
As expected if KIF5A was needed for efficient NF transport,
NF subunits accumulated in KIF5A-depleted DRGs, while
KIF5A levels were reduced to 20% of that in the controls
(three litters were examined; one representative litter is
shown in Fig. 6 A). A polyclonal antibody against the
COOH terminus of NF-H, which recognizes NF-H inde-
pendent of its phosphorylation state, revealed a significant
( 150%) increase in total NF-H protein in mutant DRGs.
The amount of NF-L was increased in mutant DRGs by an
equivalent amount ( 150%), while NF-M amounts were
increased but to a lower extent (by 20–50%). The increase
in NF-H was confirmed with the monoclonal antibody
SMI-32, which is specific for the dephosphorylated isoform
of NF-H, whereas a monoclonal antibody specific for phos-
phorylated NF-H (SMI-31) revealed a slight (10–15%) de-
crease. The type III intermediate filament protein peripherin
was also increased in the mutant DRGs, whereas the neu-
ron-specific   III-tubulin isoform was not. Increases in
NF-H, NF-M, NF-L, and peripherin were selective for the
DRGs. No obvious changes in the amounts of NF-H,
Figure 5. Loss of large caliber axons in the KIF5A
null/KIF5A
flox; Cre
synapsin mutant mice. (A) Counts of total, small ( 3  m diameter), and 
large ( 3  m diameter) myelinated axons in L5 ventral and dorsal roots from 3-wk-old control (n   4) and mutant (n   6) mice. No significant 
difference is observed between the number of mutant and control axons in the ventral root. There is a significant loss of dorsal root axons. 
*, P   0.05 (0.045); **, P   0.01 (0.002); t test. (B) Axon numbers of total, small ( 4  m), and large ( 4  m) myelinated axons in L5 ventral 
and dorsal roots from 5.5-mo-old control (1 and 2, control) and mutant (3 and 4, mutant) mice. There is a profound loss of dorsal root axons, 
especially large caliber axons. The loss of ventral root axons is not as profound as observed in the dorsal root. (C and D) Axonal diameters of 
L5 ventral root (C) and L5 dorsal root (D) from 5.5-mo-old mutant and control mice. Averaged distribution of axon diameters from the entire 
roots of two mutant and two control mice is shown. Note that in the ventral root (C), the peak of the distribution of the diameter of large caliber 
axons shifts from 7–7.5  m in controls to 5.5–6  m in mutants. Also note the obvious loss of large caliber axons in the dorsal root (D).T
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NF-M, NF-L, or peripherin were found in the brain and sci-
atic nerve (Fig. 6 B).
We also examined NF levels in sensory neurons of four of
the rare older surviving mice in which KIF5A was reduced
by Cre-induced recombination (6 wk, 3 mo, 7 mo, and 8
mo). A variable phenotype was seen in these animals, possi-
bly owing to variation in Cre-mediated KIF5A excision
among these unusual surviving animals. Although the NF
protein level was increased in the DRG of the 3-mo-old mu-
tant animal, no obvious reduction in the amount of NF pro-
teins was observed in the sciatic nerve. This animal, how-
ever, had very poor KIF5A excision. In the 7-mo-old mutant
animal, obvious reductions in the content of NFs in the
nerve and in the DRG were seen, perhaps because of sensory
neuron degeneration. Significant reductions of NF-M, NF-L,
and peripherin were observed in the sciatic nerves of the
6-wk-old and 8-mo-old mutants, accompanied by accumu-
lations of these proteins in the DRGs.  III-tubulin was
modestly reduced in sciatic nerve samples of these animals,
accompanied by a slight accumulation of these proteins in
the DRGs. These changes appeared to be selective because
the levels of other axonal proteins (KIF3A, KIF3B, and
Rab5) were unaltered at both 3 and 6 wk of age in the mu-
tant DRGs and sciatic nerves (unpublished data). Finally,
the increased accumulation of NF-H observed by immuno-
blotting of the DRG was confirmed to reflect an increase in
the amount within sensory neuron cell bodies, as judged by
elevated staining in sections of DRG from mutants but not
controls (Fig. 6, C and D).
To test further whether KIF5A mutants have a specific
defect in slow axonal transport of NFs, we bred a second
cohort of 12 3-wk-old KIF5A
null/KIF5A
flox; Cre
synapsin ani-
mals and 12 3-wk-old matched littermate control animals
from five different litters. We used these animals to assess
the integrity of several fast anterograde transport pathways
(APP, Rab3, synaptophysin, and KIF5C), using a combi-
Figure 6. Accumulation of NF proteins in DRG sensory neuron cell bodies of KIF5A
null/KIF5A
flox; Cre
synapsin mutant mice. (A) Western blot 
analyses of DRGs from the first cohort of 3-wk-old KIF5A
null/KIF5A
flox; Cre
synapsin mutant mice. In the litter shown, control DRGs (C) were 
pooled from one II/  and one Cre/  littermates; mutant DRGs (M) were pooled from two mutant littermates. Note the obvious increase 
in dephosphorylated NF-H (revealed by the lower band labeled by NF-H, a polyclonal antibody against the COOH terminus of NF-H, and 
by antibody SMI-32) as well as the increase in NF-M, NF-L, and peripherin. (B) Western blot of brain and sciatic nerve from 3-wk-old 
KIF5A
null/KIF5A
flox; Cre
synapsin mutant mice. 20  g of proteins of mutant and control (II/ ) littermates was loaded in each lane. Note the 
clear reduction of KIF5A protein in the mutant. The levels of NFs and peripherin were not significantly changed in the mutant brain and 
sciatic nerve. (C and D) Immunostaining of DRG sensory neurons of 7.5-mo-old KIF5A
null/KIF5A
flox; Cre
synapsin mutant mice. Double staining 
with KIF5A (green) and SMI-32 (recognizes dephosphorylated NF-H, red) was performed on a mutant and a control littermate. (C) Control 
DRG staining. Bottom panel, higher magnification. (D) Mutant DRG staining, higher magnification in the lower panel. Note the apparent 
intense SMI-32 staining in some DRG neurons. Bars, 200  m.T
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nation of protein accumulation in sensory neuron cell
bodies in DRGs and sciatic nerve ligation experiments
(Kamal et al., 2000). Although the small size and fragility
of the KIF5A animals and the technical difficulty in per-
forming nerve ligations on them severely limited the sam-
ple amounts available, sufficient protein from sciatic nerve
ligations of individual animals was obtained to load single
lanes on gels and probe these multiple times with different
antibodies (some of these filters could not be used for the
full antibody set, yielding a reduced n; Fig. 7 C). As be-
fore, we observed significantly reduced KIF5A protein
levels in all of the mutant DRGs compared with controls
(Fig. 7), whereas the axonal transport profile of APP,
Rab3, synaptophysin, and KIF5C was indistinguishable
from that of their control littermates. 10 out of 12
KIF5A-deficient mice exhibited striking NF protein accu-
mulation in the DRGs, whereas no significant changes
in the protein levels of APP, Rab3, and synaptophysin
were observed. Interestingly, KIF5C protein amount was
slightly decreased in the mutant DRGs, although its
abundance in the sciatic nerve and its transport behavior
were comparable in the mutant and the control. Although
further work will be necessary to understand the origin of
KIF5C reductions in the DRG, one obvious possibility is
that KIF5C may carry out functions that are redundant
with those of KIF5A, such that when less KIF5A is avail-
able for transport, more KIF5C is used to compensate for
the reduced function of KIF5A. Alternatively, KIF5C may
form heterodimers with KIF5A (Kanai et al., 2000), and
thus the amount of KIF5C may be decreased when its
binding partner is reduced.
Discussion
Previous in vitro experiments raised the possibility that kine-
sin or kinesin family members are important for slow axonal
transport of NFs in cell culture (Koehnle and Brown, 1999;
Yabe et al., 1999) and squid axoplasm (Galbraith et al.,
1999; Prahlad et al., 2000) models. This proposal has
been highly controversial with unresolved issues including
whether each of these systems even has the machinery for
slow axonal transport.
We have shown here that although loss of KIF5A causes
organismal lethality, mutant cells and tissues are remarkably
normal in appearance, and most phenotypes assessed were
normal. The only cellular phenotype we detected after post-
natal removal of KIF5A was accumulation of NF subunits
(NF-H, NF-L, and NF-M) and peripherin in the cell bodies
of DRG sensory neurons. Evidence that this accumulation is
a result of a specific deficit in slow axonal transport of NFs
comes from our observation that markers of several fast ax-
onal transport pathways (APP, Rab3, and synaptophysin)
appeared unchanged in the DRG and in sciatic nerve liga-
tion experiments. NF accumulation in the DRG was accom-
panied by a reduced number of the largest caliber sensory ax-
ons.  III-tubulin was less consistent in its behavior because
it was unchanged in younger animals, but showed behavior
indicative of defective transport in some older animals; fur-
ther work will be required to better understand whether
KIF5A plays any role in  III-tubulin transport. Although
more complex interpretations are possible, the simplest con-
clusion from these findings is that KIF5A does not have a
major role in typical kinesin-I fast axonal transport path-
ways, but does have a role in the in vivo transport of at least
Figure 7. Analysis of DRG accumulation and axonal transport in 
second cohort of 3-wk-old KIF5A
null/KIF5A
flox; Cre
synapsin mutant 
mice. (A) Axonal transport of APP, Rab3, synaptophysin, and KIF5C 
as assessed by Western blotting of proximal and distal segments 6 h 
after ligation of sciatic nerves from control and mutant animals; 
unligated controls are from the contralateral unligated nerve. Nerves 
from each animal were homogenized, and equal amounts of nerve 
proteins ( 40  g/lane) were loaded onto SDS-PAGE gels and analyzed 
by Western blotting. Data from two pairs of mice from different litters 
are shown. P, proximal side; D, distal side. (B) Analysis of DRG 
content of mutant and control animals. Approximately 12  g of DRG 
lysate from each animal was loaded into each lane. Note increased 
NF-H and NF-L levels in the mutant DRGs, whereas protein amounts 
of APP, Rab3, and synaptophysin were not obviously changed. 
(C) Summary of data from 12 mutant and 12 littermate control 
animals from five litters. SYP, synaptophysin. As many antibodies as 
possible were used for reprobing of each filter, but filter lifetime was 
inconsistent so not all probes could be used on all animals.T
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one component of slow axonal transport, the NFs. The evi-
dence also reveals an essential role for a conventional kinesin
for normal postnatal radial growth; presumably a conse-
quence of reduced slow transport of NFs, whose movement
into axons is essential for such growth (Ohara et al., 1993;
Eyer and Peterson, 1994; Zhu et al., 1997).
A fast motor in slow axonal transport?
Our quantitative immunoblot data showed a significant in-
crease of NF-H, NF-M, and NF-L by 3 wk of age in the
mutant DRGs, and thus in sensory neuron cell bodies. The
simplest explanation is that these NF subunits were synthe-
sized at normal rates but were moved out of the cell bodies
at reduced rates. Overall, the levels of these proteins were
not significantly changed in the brain, suggesting that the
cell body accumulation is not caused by up-regulation of
these proteins. Elevation of NF subunit levels in the DRG
was not accompanied by obvious reductions in the sciatic
nerve. This behavior is as expected based on two indepen-
dent lines of evidence. First, the onset of the apparent deficit
in transport is observed at 3 wk of age, the age at which sub-
stantial NF deposition and radial growth in axonal caliber
normally begin. Only a subset of axons in mutants exam-
ined at this time have detectable caliber deficits ( 250/
3,500 total axons in the sciatic nerve). Second, although
Cre-mediated excision using Cre
synapsin has been detected as
early as E12.5 (Zhu et al., 2001), it is likely that Cre exci-
sion is most active at 3 wk of age when synapsin-I promoter
activity peaks (this would be consistent with the observation
that  72% of these mutants die at  3 wk of age). Hence,
animals at this age are most likely being analyzed not long
after most recombination has occurred. We did observe re-
duced levels of NF-M, NF-L, and peripherin in the sciatic
nerves of some older animals (unpublished data), consistent
with the compromise in transport of NFs and peripherin in
the KIF5A mutant. Our data are silent on the question of
the form (subunit, oligomeric, or polymeric) of the trans-
ported material.
Our data are consistent with gene knockout studies of
NFs that have provided evidence for their role in determin-
ing the calibers of large axons. NF-L gene knockout mice
have no NFs and exhibit severe axonal hypotrophy (Zhu et
al., 1997), and NF-M knockout mice showed profound re-
duction in NF number and reduction of axonal caliber in
large myelinated axons (both motor and sensory axons) (El-
der et al., 1998a; Jacomy et al., 1999). Three labs have re-
ported on NF-H null mice. Two studies reported only a
slight reduction in the caliber of myelinated axons from the
ventral roots (Rao et al., 1998; Zhu et al., 1998), the third
study described a more pronounced reduction in the caliber
of motor axons (Elder et al., 1998b). One study also re-
ported the consequence of loss of NF-H in sensory axons
(Rao et al., 1998). Knockout of NF-H apparently inhibited
the growth of the largest caliber sensory axons,  19% of
which were lost by 9 wk of age. Thus, NF-H plays an im-
portant role in the radial growth of sensory axons and, to a
lesser extent, of motor axons.
One intriguing observation from our study is that DRG
sensory neurons are more severely affected than motor neu-
rons in the KIF5A–synapsin Cre mice. However, KIF5A is
clearly present in both spinal cord motor neurons and DRG
sensory neurons by immunolocalization. Two possible
mechanisms could explain the phenotypic difference be-
tween motor neurons and sensory neurons. First, it is possi-
ble that KIF5A excision by Cre recombinase primarily or
preferentially occurs in DRG sensory neurons but not in
spinal cord motor neurons. Second, sensory neurons could
have a specialized axonal architecture that is more depen-
dent upon KIF5A for normal functions, including NF
transport. Support for this latter possibility comes from our
observation (unpublished data) that the levels of KIF5A are
considerably higher relative to KIF5B and KIF5C in the
DRG than in other neuronal tissues (brain, spinal cord, and
sciatic nerve) examined. Evidence from other knockout
mice also supports the notion that sensory neurons might
have cytoskeletal and transport differences relative to motor
neurons. For example, although both NF-L and NF-M
knockout mice showed profound axonal atrophy (reduction
of axonal caliber) in both motor neurons and sensory neu-
rons, loss of NF-H in mice had very little effect on axonal
calibers of motor neurons but apparently inhibited the
growth of the largest caliber axons of sensory neurons (Rao
et al., 1998). Similarly, deleting BPAG1n/dystonin, a pro-
tein that may form cross-bridges between NFs and actin
filaments or NFs and microtubules, resulted in rapid de-
generation of sensory neurons but not motor neurons, pre-
sumably due to perturbed axonal architecture (Guo et al.,
1995; Yang et al., 1996, 1999). Another recent study sug-
gested the possibility of a preferential requirement for an-
other conventional kinesin, KIF5C, in maintenance of mo-
tor neurons (Kanai et al., 2000).
Although it is formally possible that loss of KIF5A has an
indirect effect on transport of NFs in sensory neurons, a di-
rect role of KIF5A in NF transport better fits our, and oth-
ers’, data (Yabe et al., 1999; Wang et al., 2000). In support
of this view, our observation that fast axonal transport ap-
pears normal in KIF5A mutants suggests that changes in NF
transport are not an indirect result of large defects in fast
transport. How might a fast transport motor, kinesin-I, par-
ticipate in slow axonal transport of NFs? A broadened peak
of radiolabeled NF subunits during continued transport has
been observed in various pulse-labeling experiments. It has
been proposed that broadening of the transported wave of
NFs reflects differential association and dissociation of indi-
vidual NFs with their putative transport motor, i.e., the fast-
est moving NFs would represent those spending relatively
more time in association with the motor, whereas the slow-
est moving NFs represent those that have dissociated from
the motor for relatively longer periods (Lasek et al., 1992,
1993; Nixon, 1992, 1998a,b). Recently, axonal transport of
an NF protein tagged with GFP has been directly observed
in cultured nerve cells (Wang et al., 2000); the data led to
the suggestion that the slow rate of slow axonal transport
may be the result of rapid movements interrupted by pro-
longed pauses. Our data now provide a missing link, the
identity of a motor that drives these movements. It is clear,
however, that our data do not rule out the possibility that
other motor proteins also participate in transport of NFs.
Likely candidates include the other pair of conventional ki-
nesins, KIF5B and KIF5C.T
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Are there other essential functions of KIF5A?
KIF5A was found to be essential for viability in neonatal an-
imals. Because KIF5A is neuron specific, it is likely that this
reflects a neuronal function that the other two KHCs
(KIF5B and KIF5C) do not provide. Consistent with this
view, the enlarged cell size of spinal cord motor neurons in
the KIF5A null mutant suggests that the defects caused by
loss of KIF5A could be related to nerve damage, perhaps re-
flecting impaired axonal transport of KIF5A cargoes. As all
NF knockout mutants are viable, we presume that the trans-
port of other, as yet unidentified, cargoes of KIF5A is essen-
tial, although it is possible that the neonatal death could be
due to axonal blockage secondary to an NF transport defect.
More studies need to be done to sort out these possibilities.
Recent work has revealed that KIF5A is defective in one
form of hereditary spastic paraplegia (SPG10) (Reid et al.,
2002), underscoring the importance of this protein and
proper axonal transport for the health of the human nervous
system. It is also striking that abnormal NF accumulations
have been observed in many neurodegenerative diseases, in-
cluding amyotrophic lateral sclerosis, Parkinson’s disease,
and Alzheimer’s disease (Julien and Mushynski, 1998; Ju-
lien, 1999). It is possible that such accumulations are caused
by impaired slow axonal transport of NFs, although the mo-
lecular basis of such blockage is obscure. KIF5A may turn
out to be an important component of the machinery that
fails in these disorders. Intriguingly, symmetrical sensory
polyneuropathy, the most common form of diabetic neu-
ropathy in humans, also has peripheral axonal degeneration,
paranodal demyelination, and loss of myelinated axons (Zo-
chodne, 1996; Yagihashi, 1997). Moreover, aberrant NF
phosphorylation was observed in sensory neurons of rats
with diabetic neuropathy (Fernyhough et al., 1999). In light
of our finding that loss of KIF5A can provoke sensory axon
degeneration, it will be of interest to test whether impaired
axonal transport resulting from KHC impairment is in-
volved in the development of these other diseases as well.
Materials and methods
Construction of the KIF5A targeting vector
A KIF5A genomic clone (encoding amino acids 98–547) isolated from a
129SVJ/Lambda FIX
®II mouse genomic library (Stratagene) was used to
construct the targeting vector. The KIF5A targeting vector was made as
follows. An  1.1-kb AvaII fragment containing two exons encoding
amino acids 239–322 (VSKTGA to TLMFGQ) and the first two nucleotides
for amino acid 323 was inserted into the BamHI site of the pflox vector by
blunt ligation. An  4.5-kb AvaII–SalI fragment (made by subcloning
AvaII–EcoRV and EcoRV–SalI fragments, and then blunt ligated together
in pSK) was blunt ligated into the XhoI site of the 1.1-kb AvaII/pflox, this
4.5-kb fragment was the right arm. The left arm was an  3.2-kb XbaI–
SpeI fragment, it was subcloned into the SalI site of the 1.1-kb AvaII  
right arm/pflox by blunt ligation. For cloning convenience, an  80-bp
SpeI–AvaII intron sequence was deleted in the targeting vector, this prob-
ably would not affect the recombination efficiency and such a short intron
sequence deletion also should not cause any phenotypic consequence.
The finished targeting vector was designated as KIF5A-KO/pflox. The re-
sulting vector had three loxP sites, the first two flanked the pGK-neo,
HSV-tk selection cassette, the second and third loxP sites flanked the 1.1-
kb AvaII fragment.
Generating chimeric mice and mouse tail DNA genotype
The KIF5A-targeted embryonic stem (ES) cells were generated as described
by Wurst and Joyner (1993). The KIF5A-KO/pflox plasmid DNA was lin-
earized with NotI and transfected into RI ES cells by electroporation. The
ES cells were allowed to grow for 24–36 h before 200  g/ml G418
(GIBCO BRL) was added for selection;  120 neomycin-resistant ES clones
were isolated after  8 d selection. Four clones were homologous recombi-
nant clones with three loxP sites; they were named as clones B2, B6, B18,
and D17. Cre recombinase (PMC Cre pGK-Hyg) was transfected into D17
ES cells and 2  M Gancyclovir was added to the medium 3–4 d after trans-
fection, the surviving clones were picked up 5 d later. Among 48 clones
selected, 30 clones were type I ES cells, 4 were type II ES cells. Type I ES
clones D17-37 and D17-38 and type II clone D17-35 were injected into
C57BL/6J blastocysts to produce chimeras. Male chimeras were used as
founders to breed F1 hybrids with C57BL/6J female mice.
Mouse tail DNAs were made as described by Wurst and Joyner (1993)
and were genotyped by PCR. Three primers (P1, P2, and Pflox) were com-
bined to perform type I genotype, the 5  primer P1 (GATACTCCAAG-
GCTGGGAACATA) and the 3  loxP primer (Pflox kpnI, CGGTACCCGGG-
GATCAATTCGAG) will produce an  300-bp mutant fragment, the P1 and
P2 primers (TGTGGAGGTCAGAGGTCAAGT) will amplify an  450-bp
wild-type band. For type II genotype, a primer set P3 (CGTTCTGGAC-
GAGGCAAAGA) and P4 (GATGGGACAGCAGCAGTGCA) will detect an
 370-bp wild-type band and an  470-bp (with the addition of  100 bp
loxP sequence) type II band. A pair of specific primers (5  primer, ACG-
TTCACCGGCATCAACGT; 3  primer, CTGCATTACCGGTCGATGCA),
which detects an  300-bp band, was used for Cre transgene genotype.
PCR conditions for all primer sets were denaturation at 95 C for 2 min, 30
cycles of denaturation at 95 C for 30 s, annealing and elongation at 72 C
for 1.5 min, and a final elongation at 72 C.
Preparation of antibodies from KHC–His tag fusion proteins
DNA fragments encoding portions of the stalk region of KIF5A and KIF5C
were subcloned into pET-23b (Novagen, Inc.) to generate COOH-terminal
His-tagged fusion proteins. KIF5A fusion construct was made by subclon-
ing a HincII–HindIII fragment (encoding amino acids 496–745, VNY-
DQKSQ to LQLELEKL) into pET-23b. KIF5C–His fusion protein construct
was generated by subcloning a PCR fragment encoding amino acids 506–
781 (DKTRANEQ to DKREQARE) into pET-23b. A comparable KIF5B fu-
sion protein containing amino acids AVNYDQKS to QARQDLK was also
generated in pET-23b.
Recombinant His-tagged KIF5A and KIF5C proteins were overexpressed
by induction of transformed BL21 (DE3) bacteria at log phase with 0.5 mM
IPTG for 2 h. The His-tagged fusion proteins were made as follows. The
bacterial pellet was resuspended in lysis buffer ([solution A] 50 mM
NaPO4, 300 mM NaCl, 0.5 mM MgCl2, 0.01% NP-40, and proteinase in-
hibitors) and lysed with a French press. The pellet, after a 25,000-rpm spin
(15 min, Sorvall 647.5 rotor), was resuspended in 6 M urea (in solution A)
for 1 h at 4 C, and then the Ni-NTA-agarose (QIAGEN) was added to the
urea-solubilized fraction (by spin at 35,000 rpm in a Ti1270 rotor for 20
min) and incubated at 4 C for 60 min. The fusion protein–bound Ni-NTA-
agarose was washed with 6 M urea/solution A, followed by a final wash
with 20 mM imidazole/6 M urea/solution A, and the fusion proteins were
eluted with 500 mM imidazole (in 6 M urea/solution A). SDS-PAGE gel
slices of each fusion protein were injected into three rabbits to produce
polyclonal sera against KIF5A or KIF5C.
Cross absorption and affinity purification were used to generate iso-
form-specific antisera. The affinity columns were prepared by coupling 20
mg of fusion proteins (reconstituted in 10 mM Hepes, pH 6.9, 50 mM
NaCl, and 2 M urea with a Millipore Ultrafree
®-4 centrifugal filter device
Biomax-30 unit) to 2 ml of Affigel-15 (Bio-Rad Laboratories) for 1 h at RT.
The uncoupled proteins were removed with several washes of 10 mM
Hepes, pH 6.9, 50 mM NaCl, and the columns were blocked with 5% BSA
for 1 h at RT, washed again, and lastly washed with 10 mM Tris (pH 7.5).
The antisera were heated to 65 C for 15 min, diluted 10-fold in 10 mM Tris
(pH 7.5), applied to the columns, and incubated overnight at 4 C. To gen-
erate KIF5A-specific antibodies, the rabbit antisera were applied to a KIF5B
and KIF5C mixed fusion protein column, the flow-through (unbound su-
pernatant) was applied to a KIF5A affinity column. The resins with bound
KIF5A antibodies were washed with 10 mM Tris (pH 7.5), 0.5 M NaCl fol-
lowed by three washes with 10 mM Tris. The antibodies were then eluted
with 0.2 M glycine (pH 2.5) and neutralized with 1/10 volume of 1 M Tris
(pH 8). The KIF5C-specific antibodies were generated by a similar strategy;
passing through a mixed KIF5A and KIF5B column to immunodeplete
cross-reacting antisera and binding to a KIF5C column to get KIF5C-spe-
cific antibodies.
Histology of mouse tissues
For KIF5A null mutants, dissected E18.5 mice brain and spinal cord were
fixed in 4% paraformaldehyde/PBS overnight at 4 C. KIF5A–synapsin CreT
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mutant mice were suffocated with carbon dioxide and transcardially per-
fused with 4% paraformaldehyde/PBS. Tissues were postfixed overnight at
4 C and then dehydrated and embedded in paraffin. Paraffin sections (7
 m) were stained with hematoxylin-eosin, or cresyl violet, and examined
by light microscopy. Images were collected with a CCD camera.
For DRG root histology, animals were perfused with 4% paraformalde-
hyde/PBS, and half of the DRGs were removed and processed for immu-
nostaining. The other half was fixed in 2% paraformaldehyde, 2.5% glutar-
aldehyde in PBS overnight at 4 C, postfixed in 1% osmium tetroxide in
PBS for 1 h, washed, dehydrated, and embedded in Epon resin (Embed
812; Electron Microscopy Sciences). Semi-thin sections were stained with
toluidine blue and examined by light microscopy.
Morphometric analysis
Axonal diameters were determined with a Bioquant Nova image analysis
system (Bioquant R&M Biometrics, Inc.). In brief, 1- m Epon sections of L5
lumbar roots were stained with toluidine blue and viewed under a 40 
lens. All myelinated axons in each root were measured. The measured
cross-sectional area of each axon was converted to a diameter of a circle
of equivalent area.
Quantitative immunoblotting analysis
Mouse tissues were homogenized in RIPA buffer (50 mM Tris-HCl, pH 8.0,
150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS). Ho-
mogenized tissues were quickly centrifuged ( 1,000 g for 5 min in a micro-
centrifuge) to remove large debris. Protein concentrations were measured by
Bradford assay (Bio-Rad Laboratories). Equal amounts of proteins from dif-
ferent genotypes were loaded on 7.5% SDS-PAGE, and the gels were trans-
ferred to PVDF membrane (Bio-Rad Laboratories). The protein blots were
blocked in TBST (0.15 M NaCl, 10 mM Tris-HCl, pH 8.0, 0.1% Tween-20)
with 5% milk and then probed with primary antibodies in the milk-TBST,
followed by HRP-conjugated goat anti–rabbit IgG or anti–mouse IgG sec-
ondary antibodies (Jackson ImmunoResearch Laboratories). A chemilumi-
nescence ECL kit (Amersham Biosciences) was used for developing the
blots. The antibodies used for blotting were affinity-purified rabbit anti-
KIF5A, used at 1:100 dilution; polyclonal Ab specific for KIF5C at 1:200;
KIF5B-specific Ab (from R. Vale, University of California San Francisco, San
Francisco, CA) at 1:100; monoclonal antibodies SMI-31 and SMI-32 (Stern-
berger Monoclonals Inc.) at 1:5,000; a polyclonal Ab against the COOH-
terminal region of NF-H at 1:5,000; mouse anti–NF-M (clone RMO-44;
Zymed Laboratories) at 1:1,000; mouse anti–NF-L at 1:5,000; rabbit anti-
peripherin (Chemicon) at 1:1,000; rabbit anti-KIF3A at 1:1,000; rabbit anti-
KIF3B at 1:1,000; rabbit anti– III-tubulin at 1:1,000; mouse anti-Rab3 (Syn-
aptic Systems GmbH) at 1:1,000; rabbit anti-synaptophysin (Synaptic Systems
GmbH) at 1:1,000; monoclonal anti-actin (Chemicon) at 1:5,000; and a
monoclonal anti– -tubulin Ab (clone DM1A; Sigma-Aldrich) at 1:10,000.
Immunostaining
Mice were euthanized with carbon dioxide and transcardially perfused
with 4% paraformaldehyde/PBS. Tissues were removed by dissection and
postfixed for 1–2 h at 4 C, followed by cryoprotection in 25% sucrose/PBS
overnight. 10- m cryostat sections were processed for immunofluores-
cence staining. Sections were blocked (5% BSA, 0.15% saponin in PBS) for
1 h at room temperature, followed by incubation in primary antibodies
overnight at 4 C. The antibodies used for staining were rabbit anti-KIF5A at
1:20; monoclonal anti-Grp78 (BIP; StressGen Biotechnologies) at 1:200;
and monoclonal Ab SMI-32 (Sternberger Monoclonals Inc.) at 1:1,000.
FITC- or Texas red–conjugated goat anti–rabbit or goat anti–mouse IgG
(Jackson ImmunoResearch Laboratories) was used as the secondary anti-
body. All images were collected with a Bio-Rad Laboratories MRC-1000
confocal imaging system.
Sciatic nerve ligation experiments
Sciatic nerve ligation experiments were done as previously described
(Hanlon et al., 1997). In brief, one sciatic nerve from each animal was li-
gated; the other nerve was unligated and served as a control. After 6 h,
 0.5 cm of nerve segment was dissected from both sides (proximal and
distal) near the ligature from each animal; two similar size segments were
dissected from the control nerve in the comparable region. Nerve seg-
ments from each individual animal were homogenized in NP-40 lysis
buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP-40) and examined
by Western blot analysis.
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